HopeStage
Back to all studies
CompletedNCT02557984

Dopamine and Opioid Blockers in Reward and Impulse-Control Tasks

About this titleRead the official source — NCT02557984
Medication studyAges 18–35SwitzerlandAddiction
The study in practice

Understand this study

Who was this study for?

This study was for healthy volunteers. Listed age limits: 18 years to 35 years. Other eligibility criteria applied.

Listed locations
ZurichSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateFebruary 2014
Recruitment status
Completed
Enrollment listed in the registry
121
Sponsor
University of Zurich
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
Switzerland
Age range
From 18 Years to 35 Years
Official registry ID
NCT02557984
Official title
Show the full official title

Dopamine D2/3- and μ-opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity in Healthy Volunteers

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Zurich

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Zurich, a university.

Did this study involve medication?

Yes. The study involved medication, including Placebo, Amisulpride and Naltrexone.

Who was this study for?

This study was for healthy volunteers. Listed age limits: 18 years to 35 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies